Education
About Us
Working with TipRanks
Follow Us
Thc Therapeutics (THCT)
:THCT
THCT Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume30.00
Average Volume (3M)1.25K
Market Cap
$12.07K
Enterprise ValueN/A
Total Cash (Recent Filing)$32.50K
Total Debt (Recent Filing)$163.59K
Price to Earnings (P/E)―
Beta875.87
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding40,226,150
10 Day Avg. Volume676
30 Day Avg. Volume1,252
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
THCT FAQ
What was Thc Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Thc Therapeutics’s market cap?
Thc Therapeutics’s market cap is $12.07K.
When is Thc Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Thc Therapeutics’s earnings last quarter?
Currently, no data Available
Is Thc Therapeutics overvalued?
According to Wall Street analysts Thc Therapeutics’s price is currently Overvalued.
Does Thc Therapeutics pay dividends?
Thc Therapeutics does not currently pay dividends.
What is Thc Therapeutics’s EPS estimate?
Thc Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Thc Therapeutics have?
Thc Therapeutics has 40,226,150 shares outstanding.
What happened to Thc Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Thc Therapeutics?
Currently, no hedge funds are holding shares in THCT
---
Company Description
Thc Therapeutics
THC Therapeutics, Inc. engages in developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The company was founded by Brandon Romanek on May 1, 2007 and is headquartered in San Diego, CA.
---
---